跳至主要内容
临床试验/NCT06394739
NCT06394739招募中不适用

RevCore for In Stent Thrombosis (REVIT)

Inari Medical30 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Inari Medical
入组人数
100
试验地点
30
主要终点
Evidence of successful stent recanalization

研究概览

简要总结

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Patients with stent age > 6 weeks
  • Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
  • RevCore Thrombectomy Catheter must enter vasculature
  • Willing and able to provide informed consent

排除标准

  • Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
  • Stents not wall apposed
  • Stents compressed to <10mm
  • Bilateral in-stent thrombosis
  • Congenital anatomic anomalies of the iliac veins
  • Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
  • Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
  • Chronic non-ambulatory status
  • Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
  • Inability to secure venous access
  • Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
  • Current participation in another investigational drug or device treatment study

结局指标

主要结局

Evidence of successful stent recanalization

时间窗: Immediately after the RevCore thrombectomy procedure for in-stent thrombosis

Defined as patency ≥50% luminal diameter utilizing intravascular ultrasound (IVUS)

次要结局

未报告次要终点

研究者

发起方
Inari Medical
申办方类型
Industry
责任方
Sponsor

研究点 (30)

Loading locations...

相似试验